India’s First Homegrown CAR T-Cell Therapy Has Roots in NCI Collaboration - Cancer Currents Blog

National Cancer Institute sent this bulletin at 02/08/2024 10:40 AM EST

Having trouble viewing this email? View it as a Web page.

India’s First Homegrown CAR T-Cell Therapy Has Roots in NCI Collaboration
02/07/2024
	Training provided by NCI scientists helped researchers in India design an effective CAR-T cell therapy, NexCAR19, that can be manufactured in India, made available at a reasonable cost, and meet the needs of patients in India’s health care system.

You are subscribed to the latest posts from Cancer Currents: An NCI Cancer Research Blog from the National Cancer Institute. Update your subscriptions.